These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4050682)

  • 1. Use of a jet mill for dispersing dry powder for inhalation studies.
    Cheng YS; Marshall TC; Henderson RF; Newton GJ
    Am Ind Hyg Assoc J; 1985 Aug; 46(8):449-54. PubMed ID: 4050682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the grinding behaviour in a single particle impact device: studies on pharmaceutical powders.
    Meier M; John E; Wieckhusen D; Wirth W; Peukert W
    Eur J Pharm Sci; 2008 May; 34(1):45-55. PubMed ID: 18400475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of nanomechanical crystal properties on the comminution process of particulate solids in spiral jet mills.
    Zügner S; Marquardt K; Zimmermann I
    Eur J Pharm Biopharm; 2006 Feb; 62(2):194-201. PubMed ID: 16202574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
    Rehman M; Shekunov BY; York P; Lechuga-Ballesteros D; Miller DP; Tan T; Colthorpe P
    Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Powder specific active dispersion for generation of pharmaceutical aerosols.
    Crowder T; Hickey A
    Int J Pharm; 2006 Dec; 327(1-2):65-72. PubMed ID: 16930884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
    Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
    Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of dust generation by free falling powders.
    Heitbrink WA; Baron PA; Willeke K
    Am Ind Hyg Assoc J; 1992 Oct; 53(10):617-24. PubMed ID: 1456205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Innovation study on Chinese medicinal materials ultrafine grinding by impacting and attriting in jet mill].
    Jing YE
    Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(1):27-9. PubMed ID: 15714794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders.
    Raula J; Thielmann F; Naderi M; Lehto VP; Kauppinen EI
    Int J Pharm; 2010 Jan; 385(1-2):79-85. PubMed ID: 19879344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental observations of dry powder inhaler dose fluidisation.
    Tuley R; Shrimpton J; Jones MD; Price R; Palmer M; Prime D
    Int J Pharm; 2008 Jun; 358(1-2):238-47. PubMed ID: 18457930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI).
    Hoe S; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2009 Sep; 38(2):88-94. PubMed ID: 19559086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets.
    Tang P; Chan HK; Chiou H; Ogawa K; Jones MD; Adi H; Buckton G; Prud'homme RK; Raper JA
    Int J Pharm; 2009 Feb; 367(1-2):51-7. PubMed ID: 18848874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deagglomeration of dry powder pharmaceutical aerosols.
    Voss A; Finlay WH
    Int J Pharm; 2002 Nov; 248(1-2):39-50. PubMed ID: 12429458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microstructural characterization of mechanically activated ZnO powders.
    Srećković T; Bernik S; Ceh M; Vojisavljević K
    J Microsc; 2008 Dec; 232(3):639-42. PubMed ID: 19094053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the milling capabilities of the F10 Fine Grind mill using Box-Behnken designs.
    Tan BM; Tay JY; Wong PM; Chan LW; Heng PW
    Eur J Pharm Biopharm; 2015 Jan; 89():208-15. PubMed ID: 25497486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.